Akari Therapeutics, Plc announced that Melissa Bradford-Klug will step down as company's Chief Operating Officer effective May 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.714 USD | -0.06% | -12.10% | -45.06% |
1st Jan change | Capi. | |
---|---|---|
-45.06% | 13.58M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- AKTX Stock
- News Akari Therapeutics, Plc
- Melissa Bradford-Klug to Step Down as Chief Operating Officer of Akari Therapeutics, Plc